Denmark stated Monday it’s going to bar the Johnson & Johnson vaccine from its Covid inoculation drive over worries about blood clots, following the same transfer towards the AstraZeneca jab.
The Danish Well being Authority famous that the European Medicines Company (EMA) “has concluded that there’s a attainable hyperlink between uncommon however extreme circumstances of blood clots” and the Johnson & Johnson drug.
Each the EMA and the World Well being Group have nevertheless recommmended the usage of the Johnson & Johnson vaccine on the premise that the advantages outweigh the dangers.
However Danish well being officers stated the present beneficial epidemiological scenario within the Scandinavian nation meant it may do with out the J&J jab, and would rely solely on the Pfizer/BioNTech and Moderna vaccines.
“The Danish Well being Authority has concluded that the advantages of utilizing the Covid-19 vaccine from Johnson & Johnson don’t outweigh the chance of inflicting the attainable adversarial impact… in those that obtain the vaccine,” the authority stated in an announcement.
“Due to this fact, the Danish Well being Authority will proceed the Danish mass vaccination programme towards Covid-19 with out the Covid-19 vaccine from Johnson & Johnson,” it added.
The well being authority famous Denmark’s epidemic was presently “beneath management,” and that “the vaccination rollout is progressing satisfactorily with different obtainable vaccines.”
Nevertheless it acknowledged that the choice would delay the vaccination marketing campaign.
In mid-April, Denmark introduced it was reducing the AstraZeneca vaccine from its vaccination marketing campaign after placing it on maintain a month earlier, citing related considerations, changing into the primary nation in Europe to fully reduce the vaccine.
Denmark has stated it may re-evaluate the usage of each vaccines ought to the scenario change.
“New information could emerge, or the scenario in Denmark could change, for instance, when it comes to an infection strain, illness burden, epidemic management, or different vaccines’ availability,” the well being authority stated.
Of Denmark’s 5.eight million inhabitants, 11.5 p.c are totally vaccinated and 23.four p.c have acquired a primary dose of the vaccine.
At the moment there are 4 vaccines permitted to be used within the EU: Pfizer-BioNTech, Moderna, AstraZeneca and Johnson & Johnson — the latter two reserved for older individuals in most European international locations.
In April, the US quickly suspended the usage of the Johnson & Johnson vaccine after it was linked to uncommon circumstances of thrombosis.
(Aside from the headline, this story has not been edited by NDTV workers and is revealed from a syndicated feed.)